Derek Lowe
Targeting rare diseases
Is working on genetic mutations that affect only a few in every thousand people risky?
Rise of the biologics
Antibodies, RNA and gene therapy don’t necessarily compete with small molecule drugs – and they all rely on chemistry
An opportunity ignored
Dismissing ideas that were ‘not invented here’ is like walking past a $100 bill
Make room for randomness in drug development
Setting free the dark horses sometimes beats the most rational planning
Philip Ball
The preprint proposition
ChemRxiv could be a golden opportunity if we embrace it
Isn't it ironic?
What has rhetoric ever done for us, asks Philip Ball
Does the Nobel prize still matter?
Outmoded, capricious and burdened with obligations – so why does everybody want one?
A 3D periodic table?
Molecular frameworks could offer whole new perspectives on our chemical world
Raychelle Burks
The murderers who dress to kill
Clothing that is literally to die for
The great art forgery blunder
Indian yellow is a pigment often used to spot fake art. But what if the reference standard was wrong?
